| Wal-mart Pharmacy 10-3102 | |
| 300 21st Ave N, Princeton, Minnesota 55371 | |
| (763) 389-1148 |
| Name | Wal-mart Pharmacy 10-3102 |
|---|---|
| Organization Name | Walmart Inc |
| Location | 300 21st Ave N, Princeton, Minnesota 55371 |
| Type | Community/Retail Pharmacy |
| Phone | (763) 389-1148 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
In recent years, the biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights. Despite this, the inherent costs and challenges that come with utilizing Big Data have caused the biopharmaceutical sector to embrace Big Data analytics much slower than other industries.
A new study by University of Alabama at Birmingham (UAB) researchers published in the February 2013 issue of Obstetrics and Gynecology found that women who have unsuccessful midurethral sling surgery for stress urinary incontinence and then undergo a second midurethral sling surgery see more quality-of-life symptom improvement than women who undergo only a first procedure.
Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company's RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.
› Verified 4 days ago
| NPI Number | 1043554504 |
| Organization Name | WALMART INC. |
| Doing Business As | WALMART PHARMACY 10-3102 |
| Type | Community/Retail Pharmacy |
| Address | 300 21st Ave N, Princeton, MN 55371 |
| Phone Number | 763-389-1148 |
News Archive
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
In recent years, the biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights. Despite this, the inherent costs and challenges that come with utilizing Big Data have caused the biopharmaceutical sector to embrace Big Data analytics much slower than other industries.
A new study by University of Alabama at Birmingham (UAB) researchers published in the February 2013 issue of Obstetrics and Gynecology found that women who have unsuccessful midurethral sling surgery for stress urinary incontinence and then undergo a second midurethral sling surgery see more quality-of-life symptom improvement than women who undergo only a first procedure.
Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company's RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.
› Verified 4 days ago
News Archive
BioSight, Ltd, an Israeli pharmaceutical development company focused on the development of innovative chemotherapy pro-drugs with reduced toxicity, announced today the closing of an investment of $13M led by the Mori Arkin's pharmaceutical investment firm, Arkin Holdings, and the US based venture firm Primera Capital. Proceeds of the financing will be used to fund a multi-center phase IIb clinical trial with the company's lead product, Astarabine™, for the treatment of AML.
In recent years, the biopharmaceutical industry has seen an explosion in the availability of Big Data that can generate valuable insights. Despite this, the inherent costs and challenges that come with utilizing Big Data have caused the biopharmaceutical sector to embrace Big Data analytics much slower than other industries.
A new study by University of Alabama at Birmingham (UAB) researchers published in the February 2013 issue of Obstetrics and Gynecology found that women who have unsuccessful midurethral sling surgery for stress urinary incontinence and then undergo a second midurethral sling surgery see more quality-of-life symptom improvement than women who undergo only a first procedure.
Response Biomedical Corporation announced that the Company has been granted a Special 510(k) U.S. FDA clearance for an update to the Company's RAMP® Influenza A/B Assay Package Insert to include analytical reactivity information for a strain of the 2009 H1N1 virus cultured from positive respiratory specimens.
› Verified 4 days ago
Coborn's Pharmacy 19 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1100 7th Ave S, Princeton, Minnesota 55371 Phone: (888) 316-8421 | |
Fairview Orthotics And Prosthetics Type: Non-Pharmacy Dispensing Site Location: 911 Northland Drive, Princeton, Minnesota 55371 Phone: (763) 389-7551 | |
Fairview Northland Pharmacy- Prince Type: Durable Medical Equipment & Medical Supplies Supplier Location: 919 Northland Dr, Princeton, Minnesota 55371 Phone: (763) 389-6622 | |
Dr Ronald F Huebsch, Optometrist Type: Durable Medical Equipment & Medical Supplies Supplier Location: 523 1st St, Princeton, Minnesota 55371 Phone: (763) 389-3150 | |
Pricnceton Vision Center Type: Eyewear Supplier (Equipment, not the service) Location: 900 S Rum River Dr, Princeton, Minnesota 55371 Phone: (763) 389-9000 |